OBJECTIVE: To determine whether mid-pregnancy levels of angiogenic markers were associated with increased risk of preterm delivery (PTD). METHODS: We studied a subcohort from the Pregnancy Outcomes and Community Health Study for whom mid-pregnancy angiogenic markers (soluble fms-like tyrosine kinase-1 [sFlt-1], soluble endoglin [sEng] and placental growth factor [PlGF]) and covariate data were available (N = 1301). Angiogenic marker levels were grouped as high/not high (sFlt-1 and sEng), low/not low (PlGF) and high/intermediate/low (sFlt-1). Associations between levels of angiogenic markers and PTD/PTD subtype were determined for women who were nonsmokers during pregnancy (N = 933). RESULTS: Low PlGF and high sEng were associated with medically-indicated PTD and PTD <35 weeks, largely due to preeclampsia (PE). Excluding PE and small-for-gestational-age infants, low sFlt-1 was positively associated with medically-indicated PTD. CONCLUSIONS: Among nonsmokers, mid-pregnancy levels of angiogenic markers may mark multiple pathways leading to PTD, only one attributable to PE.
OBJECTIVE: To determine whether mid-pregnancy levels of angiogenic markers were associated with increased risk of preterm delivery (PTD). METHODS: We studied a subcohort from the Pregnancy Outcomes and Community Health Study for whom mid-pregnancy angiogenic markers (soluble fms-like tyrosine kinase-1 [sFlt-1], soluble endoglin [sEng] and placental growth factor [PlGF]) and covariate data were available (N = 1301). Angiogenic marker levels were grouped as high/not high (sFlt-1 and sEng), low/not low (PlGF) and high/intermediate/low (sFlt-1). Associations between levels of angiogenic markers and PTD/PTD subtype were determined for women who were nonsmokers during pregnancy (N = 933). RESULTS: Low PlGF and high sEng were associated with medically-indicated PTD and PTD <35 weeks, largely due to preeclampsia (PE). Excluding PE and small-for-gestational-age infants, low sFlt-1 was positively associated with medically-indicated PTD. CONCLUSIONS: Among nonsmokers, mid-pregnancy levels of angiogenic markers may mark multiple pathways leading to PTD, only one attributable to PE.
Authors: Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi Journal: Nat Med Date: 2006-06-04 Impact factor: 53.440
Authors: R J Levine; J C Hauth; L B Curet; B M Sibai; P M Catalano; C D Morris; R DerSimonian; J R Esterlitz; E G Raymond; D E Bild; J D Clemens; J A Cutler Journal: N Engl J Med Date: 1997-07-10 Impact factor: 91.245
Authors: Bjørn Olav Åsvold; Lars J Vatten; Pål R Romundstad; Pål A Jenum; S Ananth Karumanchi; Anne Eskild Journal: Am J Epidemiol Date: 2011-02-11 Impact factor: 4.897
Authors: Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi Journal: J Clin Invest Date: 2003-03 Impact factor: 14.808
Authors: Gordon C S Smith; Jennifer A Crossley; David A Aitken; Nicola Jenkins; Fiona Lyall; Alan D Cameron; J Michael Connor; Richard Dobbie Journal: Obstet Gynecol Date: 2007-06 Impact factor: 7.661
Authors: Andrea L Conroy; Chloe R McDonald; Joel L Gamble; Peter Olwoch; Paul Natureeba; Deborah Cohan; Moses R Kamya; Diane V Havlir; Grant Dorsey; Kevin C Kain Journal: Am J Obstet Gynecol Date: 2017-10-12 Impact factor: 8.661